The Role of p53, MDM2 and c-erb B-2 Oncoproteins, Epidermal Growth Factor Receptor and Proliferation Markers in the Prognosis of Urinary Bladder Cancer

Regression Models and Life-Tables

D. R. Cox · Journal of the Royal Statistical Society Series B (Statistical Methodology) · 1972 · 39.3K citations · Full text

Public Health, Biostatistics, Hazard Identification +16

The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation

Jamil Momand, Gerard P. Zambetti, David C. Olson et al. · Cell · 1992 · 3.1K citations

Medicine, Molecular Biology, Oncology +10

Monoclonal antibodies against recombinant parts of the Ki‐67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave‐processed formalin‐fixed paraffin sections

Giorgio Cattoretti, Michael H. G. Becker, Göran Key et al. · The Journal of Pathology · 1992 · 1.5K citations

Life Sciences, Cell Biology, Pathology +14

Identification of p53 Gene Mutations in Bladder Cancers and Urine Samples

David Sidransky, Andrew von Eschenbach, Yvonne Tsai et al. · Science · 1991 · 894 citations

Medicine, Genetics, Oncology +13

Nuclear Overexpression of p53 Protein in Transitional Cell Bladder Carcinoma: A Marker for Disease Progression

A. S. Sarkis, Guido Dalbagni, C. Cordon‐Cardo et al. · JNCI Journal of the National Cancer Institute · 1993 · 536 citations

Medicine, Oncology, Pathology +15